1. Introduction
The hypothalamus-pituitary-pineal-gonadal (HPPG) axis is recognized for its important role in regulating reproductive functions. This interconnected communication called reciprocal cross-talk helps to keep both the reproductive and endocrine systems within precise boundaries and could contribute to coordinating the one mega-event reproduction. Melatonin (N-acetyl 5-methoxy tryptamine), the pineal hormone known as the ‘chemical expression of darkness’ is an indole amine synthesized within the pinealocytes and derived from the amino acid tryptophan plays a significant role in male reproduction. Melatonin is classified as a mitochondria-targeted antioxidant, functioning as a “firewall” against free radicals [
1]. It has a crucial role in governing physiological rhythms and as well as being connected to the management of various disorders, including depression, insomnia, and Alzheimer’s disease [
2]. It performs a clock and calendar function within the body [
2]. Melatonin exerts its cellular effect by interacting with free radicals via scavenging [
3], and serving as an important co-factor for quinone reductase-2 (QR-2) [
4]. It functions as a regulator of the reproductive system by influencing various processes such as spermatogenesis, testosterone production, and sexual behavior. Free radicals are perilous substances generated by various natural bodily processes such as breathing, digestion, metabolizing drugs and alcohol, and converting lipids into energy. Typically, our bodies have a built-in defense system of antioxidants to neutralize these free radicals. If this system cannot cope properly, free radicals can initiate a damaging chain of events within the body when this defense system malfunctions. According to findings it was stated that, this sequence may cause damage to DNA, disruption of important cellular processes, breakdown of cell membranes, inhibition of vital enzymes, and interference with the creation of energy [
5].
Reproduction is critically important in male rats, and the testes play key roles in this process. The testes are the integral components of the male rat's reproductive system, ensuring the continuation of the species through successful mating and fertilization. Of all infertility cases, “male factor” infertility accounts for approximately half of couple infertility (40–50% of instances), and inadequate sperm parameters can be seen in up to 2% of all males [
6]. Although the etiology of infertility in up to 60% of cases remains unclear and is referred to as idiopathic [
7]. Numerous causative elements have been found in infertile men. Lifestyle and human exposure to free radicals, environmental pollutants, and drug treatment could adversely affect the male reproductive system [
8,
9]. Glucocorticoids (GCs) are the major steroid hormones secreted by the adrenal gland. Prolonged treatment with GCs was found to cause side effects that can cause endocrine abnormalities via interfering with the anterior hypothalamic–pituitary–gonadal (HPG) axis [
10,
11]. Dexamethasone (DEX) is a synthetic glucocorticoid widely used in therapy due to its immunosuppressive and anti-inflammatory effects [
12]. These hormones have potent anti-inflammatory and immune-system inhibitory effects and because of this characteristic, they are the most prescribed medication globally [
13] and are increasingly prescribed [
14]. Research has demonstrated that dexamethasone can impact several bodily systems, including the reproductive system [
15]. The Leydig cells in the testes produce steroids, which supply the plasma level of testosterone. Receptors for glucocorticoids are made by Leydig cells thus, testicular tissue is the primary site of glucocorticoid action [
16]. The drug passes through the cell membrane to bind to its receptors in the cytoplasm, and the drug-receptor complex subsequently reaches the cell nucleus. Functional AR was needed for Sertoli cells to maintain normal spermatogenesis and testosterone production and ensure normal male fertility, by supplying Sertoli cell-specific AR to mice lacking the AR [
17]. Therefore, the expression of AR was regarded as an important symbol of androgen in cell regulation. A few research have till investigated for the effect of DEX on AR expression in the testes in our knowledge. The study aimed to investigate the neurohormone melatonin effect on reproductive impairments induced by dexamethasone in rats. For the determination of the effect of melatonin on oxidative damage and antioxidant enzymes, biochemical parameters were performed in the testes. Serum testosterone, corticosterone, LH, FSH, and melatonin were analyzed by ELISA Kit to determine the effect of melatonin on DEX-induced oxidative damage. AR, MT1, and MT2 expression levels were analyzed in the reproductive tissue testes using q RT-PCR. Melatonin in mammals mediated it actions through the membrane receptors Mt1 and Mt2. Despite the fact that melatonin has also been shown to influence testicular activity in all vertebrates, the idea that melatonin acts locally in male gonads has very little evidence. Glucocorticoids are well known for their immunosuppressive effects, but some studies indicate that they have differential effects on reproductive functions. However, how glucocorticoid influences the expression of melatonin and androgen receptors in DEX-induced animals is not clear. Hence, in our present studies, we evaluated the effect of melatonin on synthetic glucocorticoids and androgen receptor expression in testes. From our research, some evidence has been implicated suggesting that melatonin and its receptors (Mt1 & Mt2) expression, laterally interaction with androgen receptor (AR) expression in the testes, and perform a significant role in mediating reproductive functions.
4. Discussion
In earlier studies, it was found that dexamethasone administration decreased the rat's body weight [
29,
30]. This weight reduction can be partly attributed to decreased food intake, as demonstrated in earlier studies [
31,
32], Additionally, the weight loss observed in these animals is the cause of increased muscle loss and the breakdown of proteins and fats [
33]. Following the administration of DEX, sperm production may be interrupted, resulting in a reduction in the size of seminiferous tubules and a notable fall in testicular weight [
34,
35]. Administering melatonin restored both body weight gain and the weight of testes in rats intoxicated with DEX, bringing them close to normal levels. Therefore, melatonin exhibited a notable effect in mitigating the body weight loss seen in the DEX-treated rat groups. It's plausible that decreased proteolysis occurred in rats when given both dexamethasone and melatonin [
36], and the notable improvement in body weight, and testes weight could be credited to melatonin's antioxidant properties, which help prevent cellular damage caused by free radical generation in the reproductive tissue testes. In the DEX-treated group, there was shrinkage in the reproductive tissue [
37]. In the control group, there was no such shrinkage found, this is because free radicals attack the cell membrane of these organs which disrupts the structure and finally leads to shrinkage in the testes in the DEX-treated animal compared to the normal saline-treated group. However, in MEL treated group due to a depletion in lipid peroxidation and free radical attack, there was no shrinkage was seen in the testes as the usual structure was regained after the melatonin treatment. In this study, DEX led to significant changes in the histological structure of the testes and a significant decrease in testosterone levels and these findings were consistent with other reports for animals treated with DEX [
38,
39]. The degradation of Leydig cells and severe oxidative stress could be the cause of these disruptions [
40,
41,
42]. The biochemical changes brought on by DEX-induced toxicity on the testis function indices were verified by the histological changes in the testicular cells in our study [
34]. Research demonstrates that DEX suppresses the expression of the gene that codes for the steroidogenic acute regulatory protein (StAR), which is involved in the transportation of cholesterol [
43] inside Leydig cells, therefore decreasing the synthesis of testosterone.
Prior studies have shown that DEX might alter a body's healthy equilibrium and disrupt the endocrine system [
44]. The current study's outcome indicated that rats exposed to DEX had higher concentrations of FSH and LH. Furthermore, the levels of LH and FSH regulated Sertoli and Leydig cells [
44]. As testosterone levels dropped in the DEX group, the synthesis of testosterone was inhibited, which in turn reduced Leydig cells' response to LH. Conversely, the increase in serum FSH levels suggested that spermatogenesis had been destroyed in the experimental group and that this was due to either germ cell loss or injury to the Sertoli cells [
45]. A decrease in testosterone levels might be brought on by a rise in cortisol levels, which may inhibit Leydig cells by binding to GC receptors on the cell surface [
46]. The findings of this investigation align with other studies that have demonstrated that DEX is a potent modulator of apoptosis and that DEX significantly elevates gonadotropin-releasing hormone, FSH, and LH levels [
35,
38].
Dexamethasone increases the production of free radicals like ROS, upsetting the balance between oxidants and antioxidants within cells, and leading to oxidative stress [
47] (Sadeghzadeh et al., 2020). This stress causes damage to the plasma membrane through lipid peroxidation and interferes with germ-cell communication [
48]. A key biomarker indicating lipid peroxidation is TBARS, which was observed to increase in the DEX experimental group. Studies reported that injecting dexamethasone triggered lipid peroxidation and reduced antioxidant activity. Also, a similar study found that dexamethasone caused a higher ROS level and lower mRNA level of either catalase or SOD. Dexamethasone treatment increases MDA levels and decreases SOD levels in testicular [
41]. In the current investigation, the total antioxidation ability of the DEX group was significantly lower than that of the CON group. Glutathione (GSH) processes H
2O
2 and organic peroxides, thereby acting as an important antioxidant. The DEX group in our study showed decreased GSH, which is involved in glyoxalase reactions, ribonucleotide reductions to deoxyribonucleotides, protein regulation, and gene expression through the thiol-disulfide exchange [
49].
The present investigation’s DEX administration produced a remarkable drop in testicular GSH content, CAT, and SOD activity when compared to the control group [
34,
50]. The decreased GSH content in DEX control rats could be due to the decline in the activity of G-6-PD which is directly involved in the metabolism of GSH [
51] and the accumulation of ROS. G-6-PDH has a direct link to the synthesis of glutathione its decreased activity causes increased oxidative stress in the tissues, which ultimately results in cell death [
34,
52]. The other antioxidant enzymes; GR, GPX, and GST antioxidant enzymes, were also shown to be drastically reduced as a result of the high generations of the free radical load. The malondialdehyde levels also reached the control level in the dexamethasone alongside the melatonin-treated group. In other words, melatonin was able to compensate for the undesired effects of dexamethasone. Melatonin has been highly gained a lot of recognition recently due to its antioxidant properties [
53], and considering its small size and lipoprotein structure, it may easily cross the biological membranes to reach every area of the cell, including cytosol, mitochondria, nucleus, and DNA to prevent oxidative damage [
53]. Lipid peroxidation and all antioxidant enzymes appeared normal in the DEX + MEL group, suggesting that MEL has a significant antioxidant effect in testes as melatonin increases the activity of antioxidant enzymes such as superoxide dismutase, glutathione peroxidase, and glutathione reductase, and as a result, increases the antioxidant potential of the cell [
53,
54] and reduces DNA fragmentation, lipid peroxidation of the plasma membrane and also the ROS levels. The androgen receptor (AR) which binds to androgen, is essential to androgen action because it may bind DNA and promote the transcription of androgen-dependent genes [
55]. Prostate cancer and male infertility have been connected to abnormalities in the AR signaling system. Male genital abnormalities or infertility were linked to mutations or deletions of the AR genes [
56]. According to studies conducted in vitro, FSH significantly influences the expression of AR mRNA and the production of proteins in cultivated Sertoli cells [
57]. We inferred that the abnormal increase in AR expression caused by DEX resulted from two factors. Firstly, DEX-induced damage to Leydig and Sertoli cells led to decreased testosterone synthesis and concentration, thereby impairing the regulatory role of testosterone on AR expression. Consequently, DEX exposure disrupted the HPG axis, reducing AR expression and weakening the interaction between testosterone and AR. This notably suppressed testicular function in the Wistar albino rats, affecting testicular growth and maintenance [
58]. Research has discovered that melatonin can regulate the mRNA expression of the androgen receptor, indicating a possible involvement in the control of steroid receptors
. Research provided additional evidence for this, demonstrating the age-dependent effects of darkness exposure or melatonin administration on prostatic androgen receptors. These results suggest that melatonin might play a role in regulating androgen receptor expression in male rats. The majority of melatonin’s effect in mammals is mediated by Mt1 and Mt2 receptors, and melatonin can modify these receptors in response to physiological demands [
59]. It is well established that melatonin membrane receptors on the testes control reproductive activity. The expression of Mt1 and Mt2 receptors has been reported in rat testis and Sertoli cells It has been documented that rat testis and Sertoli cells express Mt1 and Mt2 receptors [
60,
61]. Sertoli cells play a crucial part in spermatogenesis efficiency and fertility [
62] (McLachlan et al.,1996). Melatonin increases the responsiveness of the Sertoli cell to FSH during gonadal development, which may help to prevent testicular damage [
63]. Studies on neurodegenerative illness have revealed that Mt1 expression and melatonin plasma levels are altered [
64]. In our results, the group treated with DEX had a noteworthy reduction in the expression of both Mt1 and Mt2 receptors.
As DEX causes oxidative stress which plays a crucial role in testicular toxicity and germ cell apoptosis which can be blocked by the administration of neurohormone melatonin. Melatonin can protect testes and Leydig cells against oxidative stress, partly through Mt1/Mt2 activation. The recovery of melatonin receptors (Mt1, and Mt2) in the testes lies behind the reason that melatonin also acts as an antioxidative reagent. The oxidative stress generated by DEX exposure was restored after the administration of exogenous melatonin. So, the testicular cells containing Mt1, and Mt2 started expressing again. It was suggested that prolonged melatonin treatment upregulates the Mt1 and Mt2 receptor expression in lymphoid tissues of tropical rodents. Long-term melatonin administration appears to upregulate Mt1 and Mt2 receptor expression in tropical rodent lymphoid tissues [
65]. Our findings corroborate other research that found that melatonin medication shows the course of illness by increasing apoptosis in response to melatonin receptor loss.
Figure 1.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on body weight of male rats. The graph represents Mean + SE, N=6. Histogram represents ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/DEX+MEL and # DEX vs DEX+MEL.
Figure 1.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on body weight of male rats. The graph represents Mean + SE, N=6. Histogram represents ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/DEX+MEL and # DEX vs DEX+MEL.
Figure 2.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on weight of testes. The graph represents Mean + SE, N=6. Histogram represents ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/DEX+MEL and # DEX vs DEX+MEL.
Figure 2.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on weight of testes. The graph represents Mean + SE, N=6. Histogram represents ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/DEX+MEL and # DEX vs DEX+MEL.
Figure 3.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on the morphology of testes. The melatonin-treated group showed no change in morphology as compared with the control group, whereas DEX treated group showed shrinkage as compared to the control. Melatonin treatment along with DEX showed recovery in morphology as compared with the DEX-treated group.
Figure 3.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on the morphology of testes. The melatonin-treated group showed no change in morphology as compared with the control group, whereas DEX treated group showed shrinkage as compared to the control. Melatonin treatment along with DEX showed recovery in morphology as compared with the DEX-treated group.
Figure 4.
Histogram represents the relative gene expression showing fold change (2^-ΔΔCT) of AR (Androgen receptor) in testes of DEX-induced rat model. Mean ± SE; N=6; */#P≤0.05, **/##P≤0.01, ***/###P≤0.001; * represents CON vs DEX; CON vs DEX+MEL; CON vs MEL: # represents DEX vs DEX+MEL; DEX vs MEL. CON= Control; DEX= Dexamethasone; DEX+MEL= Dexamethasone+ Melatonin; MEL=Melatonin.
Figure 4.
Histogram represents the relative gene expression showing fold change (2^-ΔΔCT) of AR (Androgen receptor) in testes of DEX-induced rat model. Mean ± SE; N=6; */#P≤0.05, **/##P≤0.01, ***/###P≤0.001; * represents CON vs DEX; CON vs DEX+MEL; CON vs MEL: # represents DEX vs DEX+MEL; DEX vs MEL. CON= Control; DEX= Dexamethasone; DEX+MEL= Dexamethasone+ Melatonin; MEL=Melatonin.
Figure 5.
Histogram represents the relative gene expression showing fold change (2^-ΔΔCT) of Mt1 (Melatonin receptor-1) in testes of DEX-induced rat model. Mean ± SE; N=6; */#P≤0.05, **/##P≤0.01, ***/###P≤0.001; * represents CON vs DEX; CON vs DEX+MEL; CON vs MEL: # represents DEX vs DEX+MEL; DEX vs MEL. CON= Control; DEX= Dexamethasone; DEX+MEL= Dexamethasone+ Melatonin; MEL=Melatonin.
Figure 5.
Histogram represents the relative gene expression showing fold change (2^-ΔΔCT) of Mt1 (Melatonin receptor-1) in testes of DEX-induced rat model. Mean ± SE; N=6; */#P≤0.05, **/##P≤0.01, ***/###P≤0.001; * represents CON vs DEX; CON vs DEX+MEL; CON vs MEL: # represents DEX vs DEX+MEL; DEX vs MEL. CON= Control; DEX= Dexamethasone; DEX+MEL= Dexamethasone+ Melatonin; MEL=Melatonin.
Figure 6.
Histogram represents the relative gene expression showing fold change (2^-ΔΔCT) of Mt2 (Melatonin receptor-2) in testes of DEX-induced rat model. Mean ± SE; N=6; */#P≤0.05, **/##P≤0.01, ***/###P≤0.001; * represents CON vs DEX; CON vs DEX+MEL; CON vs MEL: # represents DEX vs DEX+MEL; DEX vs MEL. CON= Control; DEX= Dexamethasone; DEX+MEL= Dexamethasone+ Melatonin; MEL=Melatonin.
Figure 6.
Histogram represents the relative gene expression showing fold change (2^-ΔΔCT) of Mt2 (Melatonin receptor-2) in testes of DEX-induced rat model. Mean ± SE; N=6; */#P≤0.05, **/##P≤0.01, ***/###P≤0.001; * represents CON vs DEX; CON vs DEX+MEL; CON vs MEL: # represents DEX vs DEX+MEL; DEX vs MEL. CON= Control; DEX= Dexamethasone; DEX+MEL= Dexamethasone+ Melatonin; MEL=Melatonin.
Figure 7.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum LH level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 7.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum LH level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 8.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum FSH level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 8.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum FSH level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 9.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum testosterone level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 9.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum testosterone level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 10.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum corticosterone level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 10.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum corticosterone level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 11.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum melatonin level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 11.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on serum melatonin level of the rat. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 12.
TS of Testes. The histological assessment showed normal histoarchitecture (H&E staining) of seminiferous tubule and seminiferous epithelium and exhibited active spermatogenesis in the control group. Melatonin treatment (alone) showed no significant alterations in testicular histology as evident from the normal histoarchitecture of the seminiferous epithelium. DEX treatment showed varying degrees of germ cell degenerative changes characterized by the presence of degenerating cells, germinal epithelium disruption, and loosening and detachment of germinal epithelium (exfoliation). Melatonin treatment along with DEX decreased the degenerative changes in the seminiferous tubule. Magnification of upper panel-100X, lower panel-200X. CON=Control, DEX=Dexamethasone, SET= Seminiferous tubules, SZ=Spermatozoa, SC=Spermatocytes, ST=Spermatids, LC=Leydig Cells, D=Degeneration, R=Recovery.
Figure 12.
TS of Testes. The histological assessment showed normal histoarchitecture (H&E staining) of seminiferous tubule and seminiferous epithelium and exhibited active spermatogenesis in the control group. Melatonin treatment (alone) showed no significant alterations in testicular histology as evident from the normal histoarchitecture of the seminiferous epithelium. DEX treatment showed varying degrees of germ cell degenerative changes characterized by the presence of degenerating cells, germinal epithelium disruption, and loosening and detachment of germinal epithelium (exfoliation). Melatonin treatment along with DEX decreased the degenerative changes in the seminiferous tubule. Magnification of upper panel-100X, lower panel-200X. CON=Control, DEX=Dexamethasone, SET= Seminiferous tubules, SZ=Spermatozoa, SC=Spermatocytes, ST=Spermatids, LC=Leydig Cells, D=Degeneration, R=Recovery.
Figure 13.
Fluorescent photomicrograph of the rat testes after dexamethasone and melatonin treatment as determined by single gel electrophoresis with Ethidium bromide (EtBr) stain. A-CON-Control group presenting intact DNA. B-DEX-showing damage DNA represented by tail marked with the blue arrow. C- presented very little damage DNA marked with the green arrow, D- MEL group presented the same as the control group marked with the white arrow. Magnification X 200.
Figure 13.
Fluorescent photomicrograph of the rat testes after dexamethasone and melatonin treatment as determined by single gel electrophoresis with Ethidium bromide (EtBr) stain. A-CON-Control group presenting intact DNA. B-DEX-showing damage DNA represented by tail marked with the blue arrow. C- presented very little damage DNA marked with the green arrow, D- MEL group presented the same as the control group marked with the white arrow. Magnification X 200.
Figure 14.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on lipid peroxidation level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 14.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on lipid peroxidation level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 15.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on total protein content of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 15.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on total protein content of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 16.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on superoxide dismutase (SOD) level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 16.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on superoxide dismutase (SOD) level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 17.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on catalase (CAT) level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 17.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on catalase (CAT) level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 18.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on reduced glutathione (GSH) level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 18.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on reduced glutathione (GSH) level of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 19.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on glutathione reductase (GR) of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 19.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on glutathione reductase (GR) of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 20.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on glutathione peroxidase (GPX) of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 20.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on glutathione peroxidase (GPX) of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 21.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on G6PDH of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 21.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on G6PDH of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.01, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL/MEL.
Figure 22.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on total glutathione-S-transferase (GST) of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.
Figure 22.
Effect of melatonin (MEL) and dexamethasone (DEX) treatment on total glutathione-S-transferase (GST) of testes. The graph represents Mean + SE, N=6. ***/###p≤0.001, **/##p≤0.05, */#p≤0.05, where * CON vs DEX/ DEX+MEL and # DEX vs DEX+MEL.